Cargando…

Psychiatric morbidity, somatic comorbidity and substance use in an adolescent psychiatric population at 3-year follow-up

Knowledge is scarce on the course of psychiatric disorders in adolescence. We aimed to assess changes in the frequency of psychiatric disorders, somatic disorders, pain, and substance use in a clinical psychiatric cohort from adolescence to young adulthood. This study is part of the Health Survey in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gårdvik, Kari Skulstad, Rygg, Marite, Torgersen, Terje, Lydersen, Stian, Indredavik, Marit Sæbø
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295167/
https://www.ncbi.nlm.nih.gov/pubmed/32671493
http://dx.doi.org/10.1007/s00787-020-01602-8
_version_ 1783725385906651136
author Gårdvik, Kari Skulstad
Rygg, Marite
Torgersen, Terje
Lydersen, Stian
Indredavik, Marit Sæbø
author_facet Gårdvik, Kari Skulstad
Rygg, Marite
Torgersen, Terje
Lydersen, Stian
Indredavik, Marit Sæbø
author_sort Gårdvik, Kari Skulstad
collection PubMed
description Knowledge is scarce on the course of psychiatric disorders in adolescence. We aimed to assess changes in the frequency of psychiatric disorders, somatic disorders, pain, and substance use in a clinical psychiatric cohort from adolescence to young adulthood. This study is part of the Health Survey in Department of Children and Youth, St. Olavs Hospital, Norway. At age 13–18 years, 717 (43.5% of eligible) participated in the first study visit (T(1)) in 2009–2011, 549 were reassessed 3 years later with telephone interview (T(2)), and 464 had diagnostic evaluation at both time points. Data included: ICD-10 diagnoses (T(1)), DSM-IV diagnoses (T(2)), self-reported pain and substance use (T(1) and T(2)). The overall rate of psychiatric disorders decreased (T(1) vs. T(2): 94.8% vs. 72.2%, p < 0.001); while, an increased rate of anxiety disorders was marked among girls (37.5% vs. 55.9%, p < 0.001), with accompanying raised frequencies of psychiatric comorbidity (14.1% vs. 42.6%, p < 0.001), somatic comorbidity (9.4% vs. 19.5%, p = 0.001), chronic pain (31.6% vs. 49.4%, p < 0.001), smoking, alcohol use and trying illicit drugs. Chronic pain, smoking and trying illicit drugs were associated with persisting psychiatric disorders, with highest risk differences for girls (RD = 25.4%, p = 0.002, RD = 15.6%, p = 0.008, RD = 18.0%, p = 0.001, respectively). Three out of four adolescents still had a psychiatric disorder after 3 years. Unlike boys, girls had an increasing rate of anxiety disorders and comorbidities. Chronic pain, smoking and trying illicit drugs were associated with persisting psychiatric disorders. Despite methodological limitations, these findings emphasize the importance of early targeted intervention for adolescents with psychiatric disorders. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00787-020-01602-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-8295167
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-82951672021-07-23 Psychiatric morbidity, somatic comorbidity and substance use in an adolescent psychiatric population at 3-year follow-up Gårdvik, Kari Skulstad Rygg, Marite Torgersen, Terje Lydersen, Stian Indredavik, Marit Sæbø Eur Child Adolesc Psychiatry Original Contribution Knowledge is scarce on the course of psychiatric disorders in adolescence. We aimed to assess changes in the frequency of psychiatric disorders, somatic disorders, pain, and substance use in a clinical psychiatric cohort from adolescence to young adulthood. This study is part of the Health Survey in Department of Children and Youth, St. Olavs Hospital, Norway. At age 13–18 years, 717 (43.5% of eligible) participated in the first study visit (T(1)) in 2009–2011, 549 were reassessed 3 years later with telephone interview (T(2)), and 464 had diagnostic evaluation at both time points. Data included: ICD-10 diagnoses (T(1)), DSM-IV diagnoses (T(2)), self-reported pain and substance use (T(1) and T(2)). The overall rate of psychiatric disorders decreased (T(1) vs. T(2): 94.8% vs. 72.2%, p < 0.001); while, an increased rate of anxiety disorders was marked among girls (37.5% vs. 55.9%, p < 0.001), with accompanying raised frequencies of psychiatric comorbidity (14.1% vs. 42.6%, p < 0.001), somatic comorbidity (9.4% vs. 19.5%, p = 0.001), chronic pain (31.6% vs. 49.4%, p < 0.001), smoking, alcohol use and trying illicit drugs. Chronic pain, smoking and trying illicit drugs were associated with persisting psychiatric disorders, with highest risk differences for girls (RD = 25.4%, p = 0.002, RD = 15.6%, p = 0.008, RD = 18.0%, p = 0.001, respectively). Three out of four adolescents still had a psychiatric disorder after 3 years. Unlike boys, girls had an increasing rate of anxiety disorders and comorbidities. Chronic pain, smoking and trying illicit drugs were associated with persisting psychiatric disorders. Despite methodological limitations, these findings emphasize the importance of early targeted intervention for adolescents with psychiatric disorders. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00787-020-01602-8) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-07-15 2021 /pmc/articles/PMC8295167/ /pubmed/32671493 http://dx.doi.org/10.1007/s00787-020-01602-8 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Contribution
Gårdvik, Kari Skulstad
Rygg, Marite
Torgersen, Terje
Lydersen, Stian
Indredavik, Marit Sæbø
Psychiatric morbidity, somatic comorbidity and substance use in an adolescent psychiatric population at 3-year follow-up
title Psychiatric morbidity, somatic comorbidity and substance use in an adolescent psychiatric population at 3-year follow-up
title_full Psychiatric morbidity, somatic comorbidity and substance use in an adolescent psychiatric population at 3-year follow-up
title_fullStr Psychiatric morbidity, somatic comorbidity and substance use in an adolescent psychiatric population at 3-year follow-up
title_full_unstemmed Psychiatric morbidity, somatic comorbidity and substance use in an adolescent psychiatric population at 3-year follow-up
title_short Psychiatric morbidity, somatic comorbidity and substance use in an adolescent psychiatric population at 3-year follow-up
title_sort psychiatric morbidity, somatic comorbidity and substance use in an adolescent psychiatric population at 3-year follow-up
topic Original Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295167/
https://www.ncbi.nlm.nih.gov/pubmed/32671493
http://dx.doi.org/10.1007/s00787-020-01602-8
work_keys_str_mv AT gardvikkariskulstad psychiatricmorbiditysomaticcomorbidityandsubstanceuseinanadolescentpsychiatricpopulationat3yearfollowup
AT ryggmarite psychiatricmorbiditysomaticcomorbidityandsubstanceuseinanadolescentpsychiatricpopulationat3yearfollowup
AT torgersenterje psychiatricmorbiditysomaticcomorbidityandsubstanceuseinanadolescentpsychiatricpopulationat3yearfollowup
AT lydersenstian psychiatricmorbiditysomaticcomorbidityandsubstanceuseinanadolescentpsychiatricpopulationat3yearfollowup
AT indredavikmaritsæbø psychiatricmorbiditysomaticcomorbidityandsubstanceuseinanadolescentpsychiatricpopulationat3yearfollowup